What is the maximum recommended dose of irbesartan?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Maximum Dose of Irbesartan

The maximum recommended dose of irbesartan is 300 mg once daily 1.

Dosing by Indication

Hypertension

  • Starting dose: 150 mg once daily
  • Maximum dose: 300 mg once daily as needed to control blood pressure 1
  • The dose can be titrated upward based on blood pressure response

Nephropathy in Type 2 Diabetic Patients

  • Recommended dose: 300 mg once daily 1
  • This is both the starting and target dose for renoprotection

Special Populations

  • Volume- or salt-depleted patients (e.g., those on vigorous diuretic therapy or hemodialysis): Start with 75 mg once daily 1

Important Clinical Context

The FDA-approved maximum of 300 mg daily is based on extensive clinical trial data demonstrating efficacy and safety at this dose. Irbesartan may be administered with or without food and can be combined with other antihypertensive agents 1.

Evidence for Higher Doses

While the FDA-approved maximum is 300 mg daily, research has explored ultrahigh doses:

  • One study evaluated doses up to 900 mg daily in type 2 diabetic patients with microalbuminuria 2
  • The 900 mg dose showed additional renoprotection (15% greater reduction in albuminuria compared to 300 mg), particularly in patients with higher baseline albuminuria 2
  • However, these ultrahigh doses are investigational and not FDA-approved

Clinical Guideline Context

Current hypertension guidelines 3 list irbesartan's usual dose range as 150-300 mg daily with once-daily frequency, consistent with FDA labeling. The guidelines emphasize that simultaneous use of an ACE inhibitor, ARB, and/or renin inhibitor is potentially harmful and not recommended 3.

For clinical practice, adhere to the FDA-approved maximum of 300 mg once daily 1. Doses beyond this threshold lack regulatory approval and should not be used outside of research protocols.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.